Splose

Private

AdelaideEnterprise Softwarehttps://splose.com/

Last Round

Series A

Feb 8, 2026

Total Funding Raised

$34.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Splose is a healthtech company that develops a practice management software designed to streamline operations for Allied Health and NDIS providers using AI and automation.

Sector

Enterprise Software

Verticals

Vertical SaaS, EHR & EMR, Medical AI, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Payment Processing Fee, Usage-Based SaaS

AI Layer

Application

Keywords

allied health softwarepractice management softwareclinical documentationNDIS provider softwarevertical SaaSmedical AIEMRpatient schedulingmedical billing softwareEHRAI scribeworkflow automationAI copilotonline formspayment processing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Splose Comps

Public and private peers based on sector, stage, and business model.

Splose comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Splose Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Feb 8, 2026
Seed	Feb 21, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Kon Knafelman

Chief Financial Officer

Executive Team

Anna Kelk

Chief Product Officer

Executive Team

Splose Investors

Notable investors and investment history

Splose investors
Investor	Rounds
South Australia Government	Grant
Spectrum Equity	Series A
Equity Venture Partners	Series A, Seed
Athletic Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 8, 2026
$32M round led by Spectrum Equity.
Jan 23, 2026
Grew 28% QoQ, from 58 to 74 employees.

View all signals

Splose Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Splose Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Splose's valuation, stock price, and market status.

Firmographic Details

HeadquartersAdelaide

Employee Range82

Year Founded2016

Last FundingFeb 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.